Goodwill and Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	May 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Aug. 22, 2022	Jul. 11, 2022
Goodwill [Line Items]
Goodwill		$ 17,905		$ 17,905
Amortization expense		6,440	$ 3,805
Goodwill, impairment losses		0
Collaboration agreement
Goodwill [Line Items]
Amortization expense		6,400	$ 3,800
In-process research and development
Goodwill [Line Items]
Useful life of Remaining In Process Research and Development	$ 2,600
In-process research and development | Collaboration agreement
Goodwill [Line Items]
Amortization expense	$ 68,700	0
La Jolla Pharmaceutical Company
Goodwill [Line Items]
Goodwill					$ 6,400
Future amortization expense, remainder of 2024		19,400
Future amortization expense, 2025		25,800
Future amortization expense, 2026		25,800
Future amortization expense, 2027		25,800
Future amortization expense, 2028		25,800
Future amortization expense, thereafter		98,700
Intangible assets pertain to product rights and developed technologies		151,000
Entasis Therapeutics Holdings Inc
Goodwill [Line Items]
Goodwill						$ 11,500
Intangible assets pertain to product rights and developed technologies		106,700
Entasis Therapeutics Holdings Inc | Collaboration agreement
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies		35,400
Entasis Therapeutics Holdings Inc | In-process research and development
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies		$ 71,300